The debate around DHT vs testosterone — which matters more — isn't academic. It has direct consequences for your libido, erectile function, and overall androgenic drive. Most men know testosterone is the primary male sex hormone, but far fewer understand that dihydrotestosterone (DHT) is the more potent androgen at the tissue level — and that suppressing it carries real costs. If you've been prescribed a 5-alpha reductase inhibitor, or you're simply trying to understand why your T levels look fine on paper but you feel anything but, this article is for you.
Testosterone (T) is produced primarily in the Leydig cells of the testes in response to luteinizing hormone (LH) from the pituitary. It circulates systemically and binds to androgen receptors (AR) throughout the body — in muscle, brain, bone, and genital tissue. It's a powerful hormone. But it's not the final word.
DHT — dihydrotestosterone — is synthesized from testosterone via the enzyme 5-alpha reductase (5-AR), which exists in two isoforms: Type 1 (skin, liver) and Type 2 (prostate, genital tissue, hair follicles). DHT binds to the androgen receptor with roughly 3 to 5 times greater affinity than testosterone and dissociates far more slowly. This means once DHT locks onto an AR, it drives gene transcription more potently and for longer. In terms of androgenic signal intensity, DHT wins by a wide margin at local tissue level.
The practical implication: tissues that express high 5-AR activity — including penile smooth muscle, the prostate, and the brain's limbic system — are largely running on DHT, not raw testosterone.
Testosterone handles the broad-stroke androgenic environment: muscle protein synthesis via AR activation in skeletal muscle, red blood cell production through erythropoietin stimulation, and systemic libido signaling through central nervous system ARs. It also aromatizes into estradiol (via CYP19A1 aromatase), which is critical for bone density, cardiovascular health, and — counterintuitively — a component of male sexual desire.
DHT, by contrast, dominates peripheral androgenic tissue responses. In the penis, DHT drives nitric oxide synthase expression in cavernosal smooth muscle, influencing the vascular relaxation cascade that underlies an erection. It's also the dominant androgen during fetal penile development and pubertal virilization. In the brain, DHT metabolites like 3α-androstanediol act on GABA-A receptors, modulating mood, aggression threshold, and sexual motivation in ways testosterone alone doesn't replicate.
So the answer to DHT vs testosterone isn't a clean winner — they operate in different compartments. But for the question of erectile function specifically, DHT's local tissue role is underappreciated and often undercut by medical interventions.
Finasteride and dutasteride — prescribed for benign prostatic hyperplasia (BPH) and male pattern baldness — work by blocking 5-AR conversion. The result is a dramatic reduction in serum and tissue DHT: finasteride suppresses DHT by approximately 65–70%, dutasteride by over 90% (blocking both Type 1 and Type 2 isoforms).
In some men, this pharmacological DHT suppression triggers what's now termed Post-Finasteride Syndrome (PFS) — a cluster of symptoms including erectile dysfunction, anorgasmia, cognitive fog, and depression. The exact mechanism is still being studied, but leading hypotheses involve altered neurosteroid production (particularly reduced allopregnanolone and 3α-androstanediol), downregulation of AR expression in penile tissue, and disrupted serotonergic signaling. Serum testosterone may remain normal or even rise — but the androgenic signal at the target tissue is gutted.
This is why men on these medications can have textbook-normal testosterone panels and still experience significant erectile dysfunction. The problem isn't testosterone. It's DHT. Understanding this distinction matters before you make any decisions about hair loss or prostate medications. The team at mensvitality.health covers the clinical tradeoffs of 5-AR inhibition in detail, including protocols some physicians use to mitigate these effects.
The symptoms overlap — fatigue, low libido, poor erections — but the mechanisms and solutions differ.
Low testosterone typically presents with systemic symptoms: reduced muscle mass, increased adiposity (particularly visceral), depressed mood, poor morning erections, and low energy. Total T below 300 ng/dL with low free T (accounting for SHBG-bound fractions) is the standard diagnostic threshold, though functional symptoms matter more than a single number.
Low DHT relative to testosterone may present more specifically as: blunted genital sensitivity, difficulty with arousal despite adequate desire, poor erectile quality even with reasonable testosterone levels, and in some cases mood dysregulation. Serum DHT can be measured directly — a ratio below roughly 1:10 (DHT:T) may be clinically meaningful depending on symptom context.
If you're using testosterone replacement therapy (TRT) — injectable testosterone cypionate, enanthate, or transdermal formulations — your DHT levels will typically rise proportionally because you're providing more substrate for 5-AR conversion. This is one reason some men on TRT report improvements in sexual function beyond what total testosterone alone would predict.
If you want to optimize the DHT side of the equation without pharmacological intervention, the levers are limited but real.
Resistance training acutely raises both testosterone and DHT, with DHT showing significant post-exercise elevation in studies using heavy compound lifts. Dietary fat intake — particularly saturated and monounsaturated fats — supports steroidogenesis at the cholesterol → pregnenolone → DHEA → testosterone axis, indirectly supporting DHT production. Zinc is a cofactor in androgen metabolism; deficiency correlates with reduced 5-AR activity and lower DHT. Body fat reduction reduces aromatase activity (which competes for the testosterone pool) and may improve the T-to-DHT conversion ratio.
Conversely, DHT is suppressed by: finasteride, dutasteride, saw palmetto (a weaker 5-AR inhibitor), high-dose biotin supplementation (can interfere with lab assays and some enzymatic pathways), and — critically — chronic alcohol consumption, which disrupts Leydig cell function and 5-AR activity simultaneously. If you're navigating lifestyle factors alongside treatment protocols, resources like stubclub.cc offer community-based men's health discussion, including firsthand accounts of what lifestyle interventions move the needle on androgenic function.
Erectile function ultimately depends on nitric oxide (NO) signaling in the corpus cavernosum. The cascade: sexual stimulus → parasympathetic activation → eNOS and nNOS generate NO → cGMP accumulation → smooth muscle relaxation → blood inflow → erection. PDE5 inhibitors (sildenafil, tadalafil) work by blocking cGMP degradation — they don't fix the upstream hormonal environment.
Both testosterone and DHT support this pathway. Testosterone maintains AR expression in cavernosal tissue and upregulates PDE5 itself (paradoxically, hypogonadal men sometimes have blunted PDE5i response because baseline NO production is too low). DHT directly influences eNOS expression and cavernosal smooth muscle health. Men with normal testosterone but suppressed DHT may find PDE5 inhibitors less effective — because the issue is androgenic, not purely vascular.
For men exploring the intersection of hormones and sexual performance with a partner, the psychological and relational dimensions matter too. woah.love addresses intimacy from a whole-person perspective — useful context when hormones are part of a larger picture.
The question of DHT vs testosterone which matters more doesn't have a single answer — it depends on what you're optimizing for. Testosterone drives systemic androgenic tone, mood, and muscle. DHT governs local tissue potency, penile function, and neurosteroid-mediated sexual drive. Suppress DHT recklessly and you can hollow out your androgenic function even with normal testosterone. Ignore testosterone and you lose the substrate that DHT depends on.
Understand both. Test both. And don't let a hair loss prescription make decisions your endocrine system can't reverse easily. If you're dealing with erectile dysfunction and aren't sure whether the root cause is hormonal, vascular, neurological, or psychological — start with a clear-eyed clinical assessment.
Get the full breakdown of what's driving your symptoms at cantgetitup.xyz — no gatekeeping, no fluff, just the mechanisms that matter.